BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6108981)

  • 1. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
    Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH
    J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum neuroleptic levels predict relapse in schizophrenic patients.
    Brown WA; Laughren T; Chisholm E; Williams BW
    Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The strategy and value of neuroleptic drug monitoring.
    Curry SH
    J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
    Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J; Sampath G; Shah A; Soni SD
    Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
    Young AS; Faraone SV; Brown WA
    J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients.
    Kucharski LT; Alexander P; Tune L; Coyle J
    Psychopharmacology (Berl); 1984; 82(3):194-8. PubMed ID: 6144127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic plasma levels.
    Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N
    Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood levels of neuroleptics: state of the art.
    Simpson GM; Yadalam K
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS; Brown WA; Laughren TP; Krantz J
    Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
    [No Abstract]   [Full Text] [Related]  

  • 14. On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics.
    Ko GN; Korpi ER; Linnoila M
    J Clin Psychopharmacol; 1985 Oct; 5(5):253-62. PubMed ID: 2864357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma level monitoring of antipsychotic drugs. Clinical utility.
    Dahl SG
    Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.
    Rao ML
    Psychopharmacology (Berl); 1986; 90(4):548-53. PubMed ID: 2880364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relations between the levels of neuroleptics and the doses, the therapeutic effects and the side effects].
    Davy JP; Moulin M; Andersson JC; Halbecq JJ; Morel P; Poilpre E
    Encephale; 1978; 4(4):293-321. PubMed ID: 33791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations.
    Calil HM; Avery DH; Hollister LE; Creese I; Snyder SH
    Psychiatry Res; 1979 Jul; 1(1):39-44. PubMed ID: 45128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic monitoring: relation between antipsychotic efficiency and radioreceptor assay of serum haloperidol.
    Odou P; Vaiva G; Luyckx M; Brunet C; Dine T; Gressier B; Cazin M; Cazin JC
    Eur J Clin Pharmacol; 1996; 50(5):357-63. PubMed ID: 8839656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radioreceptor assay for neuroleptic drugs in plasma.
    Lader SR
    J Immunoassay; 1980; 1(1):57-75. PubMed ID: 6112242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.